JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

NeoGenomics Inc

Uždarymo kaina

10.63 1.82

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.53

Max

10.69

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-19M

-45M

Pardavimai

13M

181M

Pelno marža

-24.867

Darbuotojai

2,200

EBITDA

-41M

-48M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+6.19% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-10-28

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

537M

1.4B

Ankstesnė atidarymo kaina

8.81

Ankstesnė uždarymo kaina

10.63

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

NeoGenomics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-24 16:25; UTC

Pagrindinės rinkos jėgos

Obook Shares Rise, Company Secures New Money Transmitter Licenses

2025-10-23 12:37; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Solmate Infrastructure Shares Higher on Acquisition Plans

2025-10-22 16:54; UTC

Pagrindinės rinkos jėgos

Applied DNA Sciences Shares Rise After Private Investment, Crypto Buys

2025-10-21 13:09; UTC

Uždarbis
Pagrindinės rinkos jėgos

Galaxy Digital Shares Jump on Swing to 3Q Profit, Surging Revenue

2025-10-17 15:03; UTC

Pagrindinės rinkos jėgos

Obook Shares Sink Following Public Debut

2025-10-24 13:16; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-24 13:16; UTC

Rinkos pokalbiai

Bitcoin Rises After U.S. Inflation Data Firms Rate Cut Bets -- Market Talk

2025-10-24 06:59; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-24 06:59; UTC

Rinkos pokalbiai

Bitcoin Rises on Confirmation of Trump-Xi Meeting -- Market Talk

2025-10-23 07:04; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-23 07:04; UTC

Rinkos pokalbiai

Bitcoin Edges Higher But U.S.-China Tensions Limit Recovery -- Market Talk

2025-10-22 14:05; UTC

Rinkos pokalbiai

Bitcoin Could Briefly Fall Below $100K -- Market Talk

2025-10-22 09:30; UTC

Įsigijimai, susijungimai, perėmimai

Combination of FalconX, 21Shares to Develop Derivatives, Structured Products -- WSJ

2025-10-22 09:30; UTC

Įsigijimai, susijungimai, perėmimai

Crypto Trading Firm FalconX to Buy ETF Manager 21Shares -- WSJ

2025-10-22 09:30; UTC

Įsigijimai, susijungimai, perėmimai

FalconX to Fund 21Shares Deal Using Cash, Stock -- WSJ

2025-10-22 09:30; UTC

Įsigijimai, susijungimai, perėmimai

FalconX Strikes Deal to Buy Crypto Asset Manager 21Shares -- WSJ

2025-10-22 07:57; UTC

Rinkos pokalbiai

Bitcoin Falls After Confusing U.S.-China Signals -- Market Talk

2025-10-21 10:00; UTC

Įsigijimai, susijungimai, perėmimai

Deal Set to Come Later Tuesday, Executives Say -- WSJ

2025-10-21 10:00; UTC

Įsigijimai, susijungimai, perėmimai

Coinbase Strikes Deal for Crypto-Investing Platform Echo -- WSJ

2025-10-21 10:00; UTC

Įsigijimai, susijungimai, perėmimai

Coinbase Strikes Roughly $375M Deal for Crypto-Investing Platform Echo, Executives Say -- WSJ

2025-10-21 10:00; UTC

Įsigijimai, susijungimai, perėmimai

Coinbase to Fund Deal Using Cash and Stock, Executives Say -- WSJ

2025-10-21 08:00; UTC

Rinkos pokalbiai

Bitcoin Falls as Recovery Attempts Prove Short-Lived -- Market Talk

2025-10-20 14:30; UTC

Įsigijimai, susijungimai, perėmimai

Evernorth to Raise Over $1B in SPAC Deal with Armada II

2025-10-20 07:03; UTC

Rinkos pokalbiai

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Tensions -- Market Talk

2025-10-17 10:37; UTC

Rinkos pokalbiai

Bitcoin Extends Losses as Investors Shun Risky Assets -- Market Talk

2025-10-17 07:08; UTC

Rinkos pokalbiai

Bitcoin Falls as U.S. Regional Bank Concerns, U.S.-China Tensions Weigh -- Market Talk

2025-10-16 19:37; UTC

Įsigijimai, susijungimai, perėmimai

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

2025-10-16 18:31; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-16 18:31; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-16 18:31; UTC

Rinkos pokalbiai

Charles Schwab Readies Spot Crypto Trading -- Market Talk

Akcijų palyginimas

Kainos pokytis

NeoGenomics Inc Prognozė

Kainos tikslas

By TipRanks

6.19% į viršų

12 mėnesių prognozė

Vidutinis 11.33 USD  6.19%

Aukščiausias 14 USD

Žemiausias 8 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines NeoGenomics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

5

Pirkti

5

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

7.7 / 10.27Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat